NO974687L - Kondenserte <beta>-carboliner - Google Patents

Kondenserte <beta>-carboliner

Info

Publication number
NO974687L
NO974687L NO974687A NO974687A NO974687L NO 974687 L NO974687 L NO 974687L NO 974687 A NO974687 A NO 974687A NO 974687 A NO974687 A NO 974687A NO 974687 L NO974687 L NO 974687L
Authority
NO
Norway
Prior art keywords
pct
carbolines
condensed
beta
sec
Prior art date
Application number
NO974687A
Other languages
English (en)
Other versions
NO309568B1 (no
NO974687D0 (no
Inventor
Dieter Seidelmann
Andreas Huth
Preben H Olesen
Eckhard Ottow
Jonathan Turner
Margrit Hillmann
Belinda Cole
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO974687D0 publication Critical patent/NO974687D0/no
Publication of NO974687L publication Critical patent/NO974687L/no
Publication of NO309568B1 publication Critical patent/NO309568B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO974687A 1995-04-12 1997-10-10 Kondenserte <beta>-karboliner NO309568B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19514524A DE19514524A1 (de) 1995-04-12 1995-04-12 Anellierte beta-Carboline
PCT/DE1996/000632 WO1996032392A1 (de) 1995-04-12 1996-04-03 ANELLIERTE β-CARBOLINE

Publications (3)

Publication Number Publication Date
NO974687D0 NO974687D0 (no) 1997-10-10
NO974687L true NO974687L (no) 1997-12-11
NO309568B1 NO309568B1 (no) 2001-02-19

Family

ID=7759938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974687A NO309568B1 (no) 1995-04-12 1997-10-10 Kondenserte <beta>-karboliner

Country Status (23)

Country Link
US (1) US6127368A (no)
EP (1) EP0820454B1 (no)
JP (1) JPH11503432A (no)
KR (1) KR100379585B1 (no)
CN (1) CN1072224C (no)
AT (1) ATE221068T1 (no)
AU (1) AU703635B2 (no)
CA (1) CA2217719A1 (no)
CZ (1) CZ319997A3 (no)
DE (2) DE19514524A1 (no)
HU (1) HUP9801771A3 (no)
IL (1) IL117734A (no)
MX (1) MX9707784A (no)
MY (1) MY113450A (no)
NO (1) NO309568B1 (no)
NZ (1) NZ304823A (no)
PL (1) PL185554B1 (no)
RU (1) RU2169148C2 (no)
SK (1) SK137097A3 (no)
TR (1) TR199701156T1 (no)
TW (1) TW412535B (no)
WO (1) WO1996032392A1 (no)
ZA (1) ZA962946B (no)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln

Also Published As

Publication number Publication date
WO1996032392A1 (de) 1996-10-17
ATE221068T1 (de) 2002-08-15
AU5269696A (en) 1996-10-30
PL322847A1 (en) 1998-02-16
US6127368A (en) 2000-10-03
CN1181081A (zh) 1998-05-06
TW412535B (en) 2000-11-21
IL117734A0 (en) 1996-07-23
SK137097A3 (en) 1998-08-05
DE59609482D1 (de) 2002-08-29
ZA962946B (en) 1996-09-06
IL117734A (en) 1999-08-17
JPH11503432A (ja) 1999-03-26
TR199701156T1 (xx) 1998-02-21
CZ319997A3 (cs) 1998-06-17
MY113450A (en) 2002-02-28
NO309568B1 (no) 2001-02-19
PL185554B1 (pl) 2003-05-30
NO974687D0 (no) 1997-10-10
KR100379585B1 (ko) 2004-09-04
HUP9801771A2 (hu) 1998-11-30
EP0820454B1 (de) 2002-07-24
RU2169148C2 (ru) 2001-06-20
AU703635B2 (en) 1999-03-25
EP0820454A1 (de) 1998-01-28
DE19514524A1 (de) 1996-10-17
MX9707784A (es) 1997-12-31
NZ304823A (en) 1999-06-29
CN1072224C (zh) 2001-10-03
HUP9801771A3 (en) 1999-01-28
KR19980703825A (ko) 1998-12-05
CA2217719A1 (en) 1996-10-17

Similar Documents

Publication Publication Date Title
ATE208772T1 (de) Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
MA23744A1 (fr) Procede pour la preparation de sulfonamides, compositions pharmaceutiques les contenant et leur utilisation
ES2124424T3 (es) Azadioxacicloalquenos substituidos y su empleo como fungicidas.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
SE9502921D0 (sv) New compounds
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
ATE233246T1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
NZ294878A (en) Water soluble derivatives of epipodophyllotoxin and medicaments
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
PT775143E (pt) Novos derivados de 3h-2,3-benzodiazepina 3-substituidos sua preparacao e utilizacao
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
NO974687L (no) Kondenserte &lt;beta&gt;-carboliner
DE69215085D1 (de) Aminoacylderivate von gem-diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten
ATE145647T1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
KR960700223A (ko) C-치환 디에틸렌 트리아민의 제조 방법(Process for the Production of C-Substituted Diethylenetriamines)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees